InMode Ltd. INMD 深 沪
等待开盘 12-16 09:30:00 美东时间
14.33
-0.180
-1.24%
华盛通- 最 高14.69
- 今 开14.64
- 成交量 47.28万股
- 最 低 14.31
- 昨 收 14.51
- 总市值 9.06亿
- 52周最高 19.78
- 市盈率 静 6.37
- 换手率 0.75%
- 52周最低 13.14
- 委 比 74.23%
- 总股本 6320.92万
- 历史最高 90.00
- 量 比 0.85
- 振 幅 2.62%
- 历史最低 6.53
- 每 手 1
- 风险率 1.64%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 绩后评级扎堆！高通、ARM、礼来、Snap、Robinhood等获多家大行上调目标价；DoorDash、多邻国、Figma、飞塔信息、HubSpot等遭下调目标价
高通、ARM、礼来、Snap、Robinhood等获多家大行上调目标价；Adient、DoorDash、多邻国、Figma、飞塔信息、HubSpot、康丽数码等遭大行下调目标价
11-07 10:14
UBS Maintains Neutral on InMode, Lowers Price Target to $16
UBS analyst Danielle Antalffy maintains InMode (NASDAQ:INMD) with a Neutral and lowers the price target from $16.25 to $16.
11-07 02:45
InMode Affirms FY2025 Sales Guidance of $365.000M-$375.000M vs $371.511M Est
InMode (NASDAQ:INMD) affirms FY2025 sales outlook from $365.000 million-$375.000 million to $365.000 million-$375.000 million vs $371.511 million estimate.
11-05 20:09
InMode Q3 Adj. EPS $0.38 Beats $0.35 Estimate, Sales $93.165M Beat $88.349M Estimate
InMode (NASDAQ:INMD) reported quarterly earnings of $0.38 per share which beat the analyst consensus estimate of $0.35 by 7.34 percent. This is a 45.71 percent decrease over earnings of $0.70 per share from the same
11-05 20:08
Earnings Scheduled For November 5, 2025
Companies Reporting Before The Bell • Avient (NYSE:AVNT) is estimated to report...
11-05 19:12
InMode Appoints Michael Dennison as President of North America
IRVINE, Calif., Nov. 3, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, has appointed Michael Dennison, most recently Vice Pres...
11-03 21:05
InMode to Participate in Upcoming Investor Conferences
YOKNEAM, Israel, Oct. 30, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation in the following in...
10-30 20:30
美股大行评级 | 伯恩斯坦上调阿里巴巴目标价升至200美元；麦格理上调百度评级至"跑赢大市"，目标价升至176美元
今日重点评级关注：摩根大通：维持National Energy Services"超配"评级，目标价从10美元升至19美元；Piper Sandler：维持LENZ Therapeutics"超配"评级，目标价从51美元升至67美元
10-13 11:26
Canaccord Genuity Maintains Hold on InMode, Raises Price Target to $16
Canaccord Genuity analyst Caitlin Cronin maintains InMode (NASDAQ:INMD) with a Hold and raises the price target from $14 to $16.
10-10 20:47
Needham Reiterates Hold on InModeto Hold
Needham analyst Mike Matson reiterates InMode (NASDAQ:INMD) from Hold to Hold.
10-10 18:08
